211 related articles for article (PubMed ID: 29667191)
1. Herbal medicine containing aristolochic acid and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection.
Chen CJ; Yang YH; Lin MH; Lee CP; Tsan YT; Lai MN; Yang HY; Ho WC; Chen PC;
Int J Cancer; 2018 Oct; 143(7):1578-1587. PubMed ID: 29667191
[TBL] [Abstract][Full Text] [Related]
2. Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection.
Tsan YT; Lee CH; Wang JD; Chen PC
J Clin Oncol; 2012 Feb; 30(6):623-30. PubMed ID: 22271485
[TBL] [Abstract][Full Text] [Related]
3. High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load.
Tseng TC; Liu CJ; Hsu CY; Hong CM; Su TH; Yang WT; Chen CL; Yang HC; Huang YT; Fang-Tzu Kuo S; Liu CH; Chen PJ; Chen DS; Kao JH
Gastroenterology; 2019 Dec; 157(6):1518-1529.e3. PubMed ID: 31470004
[TBL] [Abstract][Full Text] [Related]
4. The Influence of Metabolic Syndrome on the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection in Mainland China.
Tan Y; Zhang X; Zhang W; Tang L; Yang H; Yan K; Jiang L; Yang J; Li C; Yang J; Wen T; Tang H; Yan L
Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2038-2046. PubMed ID: 31533942
[TBL] [Abstract][Full Text] [Related]
5. Herbal Medicine Containing Aristolochic Acid and the Risk of Primary Liver Cancer in Patients with Hepatitis C Virus Infection.
Chen CJ; Yang YH; Lin MH; Lee CP; Tsan YT; Lai MN; Yang HY; Doyle P; Ho WC; Chen PC
Cancer Epidemiol Biomarkers Prev; 2019 Nov; 28(11):1876-1883. PubMed ID: 31409611
[TBL] [Abstract][Full Text] [Related]
6. 8 years post-marketing surveillance between Asari Radix and hepatocellular carcinoma: Nationwide population-based evidence against an association.
Chen CN; Tsai YT; Lai JN
J Ethnopharmacol; 2019 Oct; 243():112094. PubMed ID: 31323301
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effects of family history of hepatocellular carcinoma and hepatitis B virus infection on risk for incident hepatocellular carcinoma.
Loomba R; Liu J; Yang HI; Lee MH; Lu SN; Wang LY; Iloeje UH; You SL; Brenner D; Chen CJ;
Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1636-45.e1-3. PubMed ID: 23669307
[TBL] [Abstract][Full Text] [Related]
8. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis.
Ioannou GN; Splan MF; Weiss NS; McDonald GB; Beretta L; Lee SP
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):938-45, 945.e1-4. PubMed ID: 17509946
[TBL] [Abstract][Full Text] [Related]
9. Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis.
Lin CW; Lin CC; Mo LR; Chang CY; Perng DS; Hsu CC; Lo GH; Chen YS; Yen YC; Hu JT; Yu ML; Lee PH; Lin JT; Yang SS
J Hepatol; 2013 Apr; 58(4):730-5. PubMed ID: 23220252
[TBL] [Abstract][Full Text] [Related]
10. The risk of hepatocellular carcinoma among chronic hepatitis B virus-infected patients outside current treatment criteria.
Sinn DH; Kim SE; Kim BK; Kim JH; Choi MS
J Viral Hepat; 2019 Dec; 26(12):1465-1472. PubMed ID: 31332935
[TBL] [Abstract][Full Text] [Related]
11. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study.
Yu MW; Lin CL; Liu CJ; Yang SH; Tseng YL; Wu CF
Gastroenterology; 2017 Oct; 153(4):1006-1017.e5. PubMed ID: 28711626
[TBL] [Abstract][Full Text] [Related]
12. Prognosis and predictors of hepatocellular carcinoma in elderly patients infected with hepatitis B virus.
Osawa M; Akuta N; Suzuki F; Fujiyama S; Kawamura Y; Sezaki H; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Suzuki Y; Ikeda K; Kumada H
J Med Virol; 2017 Dec; 89(12):2144-2148. PubMed ID: 28667756
[TBL] [Abstract][Full Text] [Related]
13. Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan.
Wang LY; You SL; Lu SN; Ho HC; Wu MH; Sun CA; Yang HI; Chien-Jen C
Cancer Causes Control; 2003 Apr; 14(3):241-50. PubMed ID: 12814203
[TBL] [Abstract][Full Text] [Related]
14. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.
Chan HL; Hui AY; Wong ML; Tse AM; Hung LC; Wong VW; Sung JJ
Gut; 2004 Oct; 53(10):1494-8. PubMed ID: 15361502
[TBL] [Abstract][Full Text] [Related]
15. Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort study.
Wu CY; Lin JT; Ho HJ; Su CW; Lee TY; Wang SY; Wu C; Wu JC
Gastroenterology; 2014 Jul; 147(1):143-151.e5. PubMed ID: 24704525
[TBL] [Abstract][Full Text] [Related]
16. Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
Lee TY; Hsu YC; Tseng HC; Yu SH; Lin JT; Wu MS; Wu CY
JAMA Intern Med; 2019 May; 179(5):633-640. PubMed ID: 30882847
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
18. Associations between prescribed Chinese herbal medicine and risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide population-based cohort study.
Tsai TY; Livneh H; Hung TH; Lin IH; Lu MC; Yeh CC
BMJ Open; 2017 Jan; 7(1):e014571. PubMed ID: 28122837
[TBL] [Abstract][Full Text] [Related]
19. Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: a need for surveillance.
Kim GA; Lee HC; Kim MJ; Ha Y; Park EJ; An J; Lee D; Shim JH; Kim KM; Lim YS
J Hepatol; 2015 May; 62(5):1092-9. PubMed ID: 25445399
[TBL] [Abstract][Full Text] [Related]
20. Association of adjuvant antiviral therapy with risk of cancer progression and deaths in patients with hepatitis-B-virus-related hepatocellular carcinoma following curative treatment: a nationwide cohort study.
Yeh YC; Liu CJ; Kuo RN; Lai CL; Shau WY; Chen PJ; Lai MS
PLoS One; 2014; 9(7):e102051. PubMed ID: 25025231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
